Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED PAYMENTS (Tables)

v3.22.2.2
SHARE BASED PAYMENTS (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based payment expense
The following table presents share-based payment expense for the three and nine months ended September 30, 2022 and 2021:
 
  Three months ended September 30, Nine months ended September 30,
  2022 2021 2022 2021
Restricted stock $ 951  $ 1,576  $ 2,902  $ 3,511 
Stock options —  162  59  721 
Warrants 340  368  1,019  1,115 
Total $ 1,291  $ 2,106  $ 3,980  $ 5,347 
Schedule of company’s outstanding stock purchase warrants
Restricted stock activity for the nine months ended September 30, 2022 is presented in the following table:
 
  Shares Weighted Average Grant Date Fair Value
Nonvested, December 31, 2021
483,750  $ 20.19 
Granted 983,749  $ 9.21 
Vested (294,566) $ 9.94 
Forfeited (500,350) $ 20.05 
Nonvested, September 30, 2022
672,583  $ 6.07 
Schedule of company’s outstanding stock purchase warrants
The table below summarizes all option activity under all plans during the nine months ended September 30, 2022:
 
Options Shares Weighted -
Average
Exercise
Price
Weighted -
Average
Remaining
Contractual
Term
Weighted -
Average
Grant Date
Fair Value
Outstanding at December 31, 2021
906,425  $ 4.38  2.85 $ 2.45 
Granted —  —  —  — 
Exercised (26,000) 4.14  —  1.92 
Forfeited or expired (247,427) 5.36  —  2.97 
Outstanding at September 30, 2022
632,998  $ 4.01  2.07 $ 2.26 
Options vested at September 30, 2022
632,998  $ 4.01  2.07 $ 2.26 
Schedule of company’s outstanding stock purchase warrants
A summary of the status of the Company’s outstanding stock purchase warrants for the nine months ended September 30, 2022 is as follows:
 
  Warrants Weighted Average
Exercise Price
Outstanding at December 31, 2021
330,884  $ 22.14 
Issued —  — 
Exercised (48,387) 3.50 
Forfeited —  — 
Outstanding at September 30, 2022
282,497  $ 25.33